Doxazosin mesylate
- Product NDC
- 59762-1390
- 11-digit product format
- 597621390
- Labeler code
- 59762
- Product ID
- 59762-1390_af51b645-f7da-4e48-84b3-59bcc153937b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxazosin mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- NDA019668
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2025-09-24
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin mesylate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXAZOSIN MESYLATE | 4 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197625, 197626, 197627, 197628 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 07a517fc-5845-3816-0f81-0a121804ec9e | Product name | 6 | 20250107 |
| 171dd63c-7eea-ede4-c010-4c25ba0a1087 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-1390-7 | Doxazosin mesylate | 100 in 1 BOTTLE | TABLET | 100 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-1390-7 | EA - Each | 59762-1390 | 57d4e148-5377-4e06-a8f7-6f12af8f6356 | 1 | 2025-10-14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-1390 | DOXAZOSIN MESYLATE TABLET [MYLAN PHARMACEUTICALS INC.] | 1 | Current NDC, 1 package rows | 20250511_2e524986-7903-416f-b2b8-d27295103e75.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197625 | doxazosin mesylate 1 MG Oral Tablet | PSN | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197627 | doxazosin mesylate 4 MG Oral Tablet | PSN | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197628 | doxazosin mesylate 8 MG Oral Tablet | PSN | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197625 | doxazosin 1 MG Oral Tablet | SCD | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197627 | doxazosin 4 MG Oral Tablet | SCD | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197628 | doxazosin 8 MG Oral Tablet | SCD | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197625 | doxazosin (as doxazosin mesylate) 1 MG Oral Tablet | SY | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197627 | doxazosin (as doxazosin mesylate) 4 MG Oral Tablet | SY | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197628 | doxazosin (as doxazosin mesylate) 8 MG Oral Tablet | SY | 2e524986-7903-416f-b2b8-d27295103e75 | 2 |
| 197627 | doxazosin mesylate 4 MG Oral Tablet | PSN | 445dc831-1960-4b25-e063-6294a90a6efd | 1 |
| 197627 | doxazosin 4 MG Oral Tablet | SCD | 445dc831-1960-4b25-e063-6294a90a6efd | 1 |
| 197627 | doxazosin (as doxazosin mesylate) 4 MG Oral Tablet | SY | 445dc831-1960-4b25-e063-6294a90a6efd | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 59762-1390-7 | 59762139007 | 100 TABLET in 1 BOTTLE (59762-1390-7) | 100 tablet | 2025-09-24 | No | No | Current |